New preclinical data on the antifibrotic effects of tasquinimod in myelofibrosis to be presented at EHA 2023
Lund, May 11 2023 – Active Biotech announces today that new data on the mechanisms by which tasquinimod ameliorates bone marrow fibrosis in a murine model of myelofibrosis will be presented in... | May 11, 2023